GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd (SHSE:688336) » Definitions » Cyclically Adjusted Price-to-FCF

Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336) Cyclically Adjusted Price-to-FCF : 691.67 (As of Jun. 07, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Sunshine Guojian Pharmaceutical (Shanghai) Co Cyclically Adjusted Price-to-FCF?

As of today (2025-06-07), Sunshine Guojian Pharmaceutical (Shanghai) Co's current share price is ¥62.25. Sunshine Guojian Pharmaceutical (Shanghai) Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was ¥0.09. Sunshine Guojian Pharmaceutical (Shanghai) Co's Cyclically Adjusted Price-to-FCF for today is 691.67.

The historical rank and industry rank for Sunshine Guojian Pharmaceutical (Shanghai) Co's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

SHSE:688336' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 139.73   Med: 215.73   Max: 644.44
Current: 629.81

During the past years, Sunshine Guojian Pharmaceutical (Shanghai) Co's highest Cyclically Adjusted Price-to-FCF was 644.44. The lowest was 139.73. And the median was 215.73.

SHSE:688336's Cyclically Adjusted Price-to-FCF is ranked worse than
96.12% of 103 companies
in the Biotechnology industry
Industry Median: 49.09 vs SHSE:688336: 629.81

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Sunshine Guojian Pharmaceutical (Shanghai) Co's adjusted free cash flow per share data for the three months ended in Mar. 2025 was ¥0.099. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is ¥0.09 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Sunshine Guojian Pharmaceutical (Shanghai) Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Sunshine Guojian Pharmaceutical (Shanghai) Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunshine Guojian Pharmaceutical (Shanghai) Co Cyclically Adjusted Price-to-FCF Chart

Sunshine Guojian Pharmaceutical (Shanghai) Co Annual Data
Trend Dec12 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 199.47 226.74

Sunshine Guojian Pharmaceutical (Shanghai) Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 192.99 183.53 209.34 226.74 303.50

Competitive Comparison of Sunshine Guojian Pharmaceutical (Shanghai) Co's Cyclically Adjusted Price-to-FCF

For the Biotechnology subindustry, Sunshine Guojian Pharmaceutical (Shanghai) Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sunshine Guojian Pharmaceutical (Shanghai) Co's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sunshine Guojian Pharmaceutical (Shanghai) Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Sunshine Guojian Pharmaceutical (Shanghai) Co's Cyclically Adjusted Price-to-FCF falls into.


;
;

Sunshine Guojian Pharmaceutical (Shanghai) Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Sunshine Guojian Pharmaceutical (Shanghai) Co's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=62.25/0.09
=691.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunshine Guojian Pharmaceutical (Shanghai) Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Sunshine Guojian Pharmaceutical (Shanghai) Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.099/115.1156*115.1156
=0.099

Current CPI (Mar. 2025) = 115.1156.

Sunshine Guojian Pharmaceutical (Shanghai) Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201012 0.131 89.289 0.169
201103 -0.002 91.154 -0.003
201106 0.051 91.612 0.064
201109 0.087 92.711 0.108
201112 0.062 92.885 0.077
201203 0.090 94.367 0.110
201206 0.055 93.495 0.068
201209 0.104 94.482 0.127
201212 0.126 95.237 0.152
201303 -0.009 96.372 -0.011
201306 -0.053 95.984 -0.064
201309 0.081 97.332 0.096
201612 0.000 102.600 0.000
201712 0.000 104.500 0.000
201812 0.000 106.500 0.000
201903 0.034 107.700 0.036
201906 0.167 107.700 0.178
201909 0.372 109.800 0.390
201912 0.246 111.200 0.255
202003 -0.094 112.300 -0.096
202006 -0.094 110.400 -0.098
202009 -0.081 111.700 -0.083
202012 -0.174 111.500 -0.180
202103 -0.219 112.662 -0.224
202106 -0.333 111.769 -0.343
202109 -0.060 112.215 -0.062
202112 -0.245 113.108 -0.249
202203 0.065 114.335 0.065
202206 0.008 114.558 0.008
202209 -0.013 115.339 -0.013
202212 -0.041 115.116 -0.041
202303 -0.105 115.116 -0.105
202306 0.075 114.558 0.075
202309 0.148 115.339 0.148
202312 0.195 114.781 0.196
202403 0.074 115.227 0.074
202406 -0.035 114.781 -0.035
202409 -0.031 115.785 -0.031
202412 -0.006 114.893 -0.006
202503 0.099 115.116 0.099

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Sunshine Guojian Pharmaceutical (Shanghai) Co  (SHSE:688336) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Sunshine Guojian Pharmaceutical (Shanghai) Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Sunshine Guojian Pharmaceutical (Shanghai) Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Sunshine Guojian Pharmaceutical (Shanghai) Co Business Description

Traded in Other Exchanges
N/A
Address
No.399 Libing Road, China (Shanghai) Pilot Free Trade Zone, Shanghai, CHN, 201203
Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd is a biopharmaceutical company providing safe and effective clinical solutions for the treatment of major diseases such as autoimmune diseases and tumors. The company engages in in research and development, manufacturing and commercialization of therapeutic antibody drugs in China. Its products portfolio includes YISAIPU and Xenopax. Its products in pipeline include 302H, 304R, 602, 601A, 609A and 301S.
Executives
Weng Zhi Bing Core technical personnel
Huang Hao Min Core technical personnel

Sunshine Guojian Pharmaceutical (Shanghai) Co Headlines

No Headlines